Teva Pharmaceutical's market cap is currently $22.34B. The company's EPS TTM is $0.66; its P/E ratio is ―; Teva Pharmaceutical is scheduled to report earnings on July 30, 2025, and the estimated EPS forecast is $0.67. See an overview of income statement, balance sheet, and cash flow financials.
